Name
D01 - Adolescent Psychopharmacology- Implementing Point-of-care Decision Support Tools to Weave Guidelines and Expert Opinion in to Practice
Date & Time
Friday, October 25, 2024, 10:00 AM - 11:00 AM
Location Name
Mission A
Description

The treatment of behavioral health conditions in adolescents is a critical component of mental health care, as this developmental stage is pivotal for psychological and emotional growth. Effective management of these conditions requires a comprehensive understanding of psychopharmacology to ensure that medications are used appropriately, considering the unique physiological and psychological aspects of adolescent patients. The incorporation of psychopharmacological knowledge into treatment plans can significantly improve outcomes for young individuals by reducing symptoms, improving quality of life, and preventing long-term consequences associated with untreated mental health issues. Applying psychopharmacological expertise in adolescent behavioral health is essential for fostering resilient, healthy individuals and communities.

Speakers
Ryan Laschober MD, Associate Program Director, Waco Family Medicine Residency, Waco, TX
Zach Sartor MD, FAAFP, Associate Program Director, Director for Primary Care Addiction Medicine, Waco Family Medicine,
Ryan Laschober Zach Sartor
Co-Authors
Zach Sartor, MD- Associate Program Director at Waco Family Medicine Residency and Associate Editor of the Waco Guide to Psychopharmacology in Primary Care Lance Kelley, PHD- Chief Behavioral Health Officer at Waco Family Medicine and Associate Editor of the Waco Guide to Psychopharmacology in Primary Care
Content Level
All Audience
Tags
Behavioral Medicine Topics (e.g., insomnia, medication adherence), Medical, Pediatrics, Pharmacology
Session Type
Concurrent
SIG or Committee
Peds, Medical
Slideshow link
View Slideshow
Handout 1 Link
View Handout 1
Objective 1
Examine the significance of understanding adolescent psychopharmacology prescribing practices, emphasizing the need for comprehensive knowledge among healthcare professionals.
Objective 2
Evaluate the Waco Guide to Psychopharmacology in primary care, highlighting its role as an essential, cost-free, and non-industry-funded resource in managing behavioral health conditions in adolescents.
Objective 3
Engage in practical exercises utilizing the Waco Guide through typical case scenarios, focusing on the implementation of psychopharmacology best practices in adolescent patient care.
Content Reference 1

Laschober RD, Kelley LP, Sartor ZR, Johnson S, Griggs JO. Waco Guide to Psychopharmacology in Primary Care. https://wacoguide.org/

Content Reference 2

Faghri NMA, Boisvert CM, Faghri S. Understanding the expanding role of primary care physicians (PCPs) to primary psychiatric care physicians (PPCPs): enhancing the assessment and treatment of psychiatric conditions. Mental health in family medicine. 2010;7(1):17. https://www.ncbi.nlm. nih.gov/pmc/articles/PMC2925161/

Content Reference 3

Institute of Medicine Committee on Quality of Health Care in A. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press (US). Copyright 2001 by the National Academy of Sciences. All rights reserved.; 2001

Content Reference 4

Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). Nov-Dec 2001;20(6):64-78. doi:10.1377/hlthaff.20.6.64

Content Reference 5

Sutton, R.T., Pincock, D., Baumgart, D.C. et al. An overview of clinical decision support systems: benefits, risks, and strategies for success. npj Digit. Med. 3, 17 (2020). https://doi.org/10.1038/s41746-020-0221-y